Sex hormones and cardiometabolic risk

J.S.M. Brand

Sex hormones and cardiometabolic risk

J.S.M. Brand

Research output: Thesis › Doctoral thesis 1 (Research UU / Graduation UU)

Abstract

In this thesis, we set out to investigate the complex relationship between endogenous sex hormones and cardiometabolic risk in men and women. The first part of this thesis is devoted to studies in women, and the second part describes the association between sex hormones and cardiometabolic risk in men. In Chapter 2 we report on the relationship between menopausal age, reproductive lifespan and type 2 diabetes risk. We studied this association in the InterAct study, a case-cohort study nested in the European Prospective Investigation in Cancer and Nutrition (EPIC). In Chapter 3 we examined whether metabolic risk accelerates menopausal onset. Here, we investigated the impact of diabetes and age at diagnosis on timing of natural menopause in the EPIC cohort. As smoking is clearly associated with menopausal age and risk of cardiometabolic disease, we studied the association between smoking habits and sex hormone concentrations in postmenopausal women in Chapter 4. After reviewing the literature on testosterone, SHBG and cardiovascular health in women (Chapter 5), we report on the results of a meta-analysis investigating the association of endogenous testosterone and SHBG with the metabolic syndrome in Chapter 6. In this literature-based meta-analysis, a significant amount of between-study heterogeneity was observed. Therefore, in Chapter 7 we conducted an individual participant data (IPD) meta-analysis to identify sources of this heterogeneity. Chapter 8 describes the association between testosterone, SHBG and glycated haemoglobin in men and Chapter 9 reports on the association with total and differential white blood cell count, a non-traditional CVD risk factor. Both studies have a cross-sectional design and were conducted in the EPIC-Norfolk cohort. Chapter 10 describes the association between endogenous sex hormones and markers of subclinical atherosclerosis in men. In Chapter 11, the main findings are discussed with recommendations for further research, and Chapter 12 summarizes the results reported in this thesis.

Original language	English
Qualification	Doctor of Philosophy
Awarding Institution	Utrecht University
Supervisors/Advisors	van der Schouw, Yvonne, Primary supervisor
Award date	24 Oct 2012
Publisher	Utrecht University
Print ISBNs	978-94-6108-342-5
Publication status	Published - 24 Oct 2012

Access to Document

Brand
Embargoed Access
Final published version, 4.39 MB
Brand
Embargoed Access
Final published version, 41 KB

Cite this

@phdthesis{992c40f4567d4b779291dbde5f959fdb,

title = "Sex hormones and cardiometabolic risk",

abstract = "In this thesis, we set out to investigate the complex relationship between endogenous sex hormones and cardiometabolic risk in men and women. The first part of this thesis is devoted to studies in women, and the second part describes the association between sex hormones and cardiometabolic risk in men. In Chapter 2 we report on the relationship between menopausal age, reproductive lifespan and type 2 diabetes risk. We studied this association in the InterAct study, a case-cohort study nested in the European Prospective Investigation in Cancer and Nutrition (EPIC). In Chapter 3 we examined whether metabolic risk accelerates menopausal onset. Here, we investigated the impact of diabetes and age at diagnosis on timing of natural menopause in the EPIC cohort. As smoking is clearly associated with menopausal age and risk of cardiometabolic disease, we studied the association between smoking habits and sex hormone concentrations in postmenopausal women in Chapter 4. After reviewing the literature on testosterone, SHBG and cardiovascular health in women (Chapter 5), we report on the results of a meta-analysis investigating the association of endogenous testosterone and SHBG with the metabolic syndrome in Chapter 6. In this literature-based meta-analysis, a significant amount of between-study heterogeneity was observed. Therefore, in Chapter 7 we conducted an individual participant data (IPD) meta-analysis to identify sources of this heterogeneity. Chapter 8 describes the association between testosterone, SHBG and glycated haemoglobin in men and Chapter 9 reports on the association with total and differential white blood cell count, a non-traditional CVD risk factor. Both studies have a cross-sectional design and were conducted in the EPIC-Norfolk cohort. Chapter 10 describes the association between endogenous sex hormones and markers of subclinical atherosclerosis in men. In Chapter 11, the main findings are discussed with recommendations for further research, and Chapter 12 summarizes the results reported in this thesis.",

author = "J.S.M. Brand",

year = "2012",

month = oct,

day = "24",

language = "English",

isbn = "978-94-6108-342-5",

publisher = "Utrecht University",

type = "Doctoral thesis 1 (Research UU / Graduation UU)",

school = "Utrecht University",

}

TY - THES

T1 - Sex hormones and cardiometabolic risk

AU - Brand, J.S.M.

PY - 2012/10/24

Y1 - 2012/10/24

N2 - In this thesis, we set out to investigate the complex relationship between endogenous sex hormones and cardiometabolic risk in men and women. The first part of this thesis is devoted to studies in women, and the second part describes the association between sex hormones and cardiometabolic risk in men. In Chapter 2 we report on the relationship between menopausal age, reproductive lifespan and type 2 diabetes risk. We studied this association in the InterAct study, a case-cohort study nested in the European Prospective Investigation in Cancer and Nutrition (EPIC). In Chapter 3 we examined whether metabolic risk accelerates menopausal onset. Here, we investigated the impact of diabetes and age at diagnosis on timing of natural menopause in the EPIC cohort. As smoking is clearly associated with menopausal age and risk of cardiometabolic disease, we studied the association between smoking habits and sex hormone concentrations in postmenopausal women in Chapter 4. After reviewing the literature on testosterone, SHBG and cardiovascular health in women (Chapter 5), we report on the results of a meta-analysis investigating the association of endogenous testosterone and SHBG with the metabolic syndrome in Chapter 6. In this literature-based meta-analysis, a significant amount of between-study heterogeneity was observed. Therefore, in Chapter 7 we conducted an individual participant data (IPD) meta-analysis to identify sources of this heterogeneity. Chapter 8 describes the association between testosterone, SHBG and glycated haemoglobin in men and Chapter 9 reports on the association with total and differential white blood cell count, a non-traditional CVD risk factor. Both studies have a cross-sectional design and were conducted in the EPIC-Norfolk cohort. Chapter 10 describes the association between endogenous sex hormones and markers of subclinical atherosclerosis in men. In Chapter 11, the main findings are discussed with recommendations for further research, and Chapter 12 summarizes the results reported in this thesis.

AB - In this thesis, we set out to investigate the complex relationship between endogenous sex hormones and cardiometabolic risk in men and women. The first part of this thesis is devoted to studies in women, and the second part describes the association between sex hormones and cardiometabolic risk in men. In Chapter 2 we report on the relationship between menopausal age, reproductive lifespan and type 2 diabetes risk. We studied this association in the InterAct study, a case-cohort study nested in the European Prospective Investigation in Cancer and Nutrition (EPIC). In Chapter 3 we examined whether metabolic risk accelerates menopausal onset. Here, we investigated the impact of diabetes and age at diagnosis on timing of natural menopause in the EPIC cohort. As smoking is clearly associated with menopausal age and risk of cardiometabolic disease, we studied the association between smoking habits and sex hormone concentrations in postmenopausal women in Chapter 4. After reviewing the literature on testosterone, SHBG and cardiovascular health in women (Chapter 5), we report on the results of a meta-analysis investigating the association of endogenous testosterone and SHBG with the metabolic syndrome in Chapter 6. In this literature-based meta-analysis, a significant amount of between-study heterogeneity was observed. Therefore, in Chapter 7 we conducted an individual participant data (IPD) meta-analysis to identify sources of this heterogeneity. Chapter 8 describes the association between testosterone, SHBG and glycated haemoglobin in men and Chapter 9 reports on the association with total and differential white blood cell count, a non-traditional CVD risk factor. Both studies have a cross-sectional design and were conducted in the EPIC-Norfolk cohort. Chapter 10 describes the association between endogenous sex hormones and markers of subclinical atherosclerosis in men. In Chapter 11, the main findings are discussed with recommendations for further research, and Chapter 12 summarizes the results reported in this thesis.

M3 - Doctoral thesis 1 (Research UU / Graduation UU)

SN - 978-94-6108-342-5

PB - Utrecht University

ER -

Sex hormones and cardiometabolic risk

Abstract

Access to Document

Fingerprint

Cite this